Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.3826
Peer-review started: January 27, 2021
First decision: March 8, 2021
Revised: March 15, 2021
Accepted: March 23, 2021
Article in press: March 23, 2021
Published online: June 6, 2021
Processing time: 106 Days and 23.7 Hours
Organ transplantation is the ultimate treatment for end-stage diseases such as heart and liver failure. However, the severe shortage of donor organs has limited the organ transplantation progress. Xenogeneic stem cell transplantation provides a new strategy to solve this problem. Researchers have shown that xenogeneic stem cell transplantation has significant therapeutic effects and broad application prospects in treating liver failure, myocardial infarction, advanced type 1 diabetes mellitus, myelosuppression, and other end-stage diseases by replacing the dysfunctional cells directly or improving the endogenous regenerative milieu. In this review, the sources, problems and solutions, and potential clinical appli
Core Tip: The severe shortage of donor organs generates long waiting lists for patients with end-stage diseases anticipating organ transplantation and ultimately leads to the deaths for those who are not fortunate to receive an organ. Xenogeneic stem cell transplantation provides a new strategy to solve this problem. In this review, we summarize possible problems and solutions and the clinical prospects of xenogeneic stem cell transplantation.
